Followers | 0 |
Posts | 1,934 |
Boards Moderated | 0 |
Alias Born | 03/04/2019 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RBII Perhaps most promising, however, are the results from recent studies indicating that CBD may be a highly effective treatment for opioid use disorder.
$RBII the CBD only Cannophen variant dovetails neatly with the segment of Rising Biosciences business model specializing in physician and behavioral health facilities management for the treatment of substance abuse and mental health disorders.
$RBII will be able to deploy a deeper arsenal of marketing and distribution solutions for a CBD only product, including avenues such as online sales platforms.
$RBII closed down 32.14 percent on Monday, July 22, 2019, on 2.3 times normal volume.
$PAOG The Cannabis Cup offered us a chance to showcase the effectiveness of our products to leading industry insiders.
$PAOG It was an amazing learning experience for the PAOG executive team, and we were proud to debut Cannophen™ at such a world class event.
$PAOG CEO Karl Riedel announced, “We were very excited to launch Cannophen™ and Fender Benders™ at the HIGH TIMES Michigan Cannabis Cup."
Good to see you Game
$RBII licenses Cannophen to $PAOG as exclusive manufacturer.
Cannophen has a super fast, easily absorbed delivery system, so none of that CBD or THC goodness goes to waste. $PAOG
That volume is a good sign. $PAOG
Hearing some positive developments are in play for $PAOG
thinking we might have news this week. $PAOG
Definitely worth watching closely this week $PAOG
Cannophen CBD only should really drive some revenues here. $PAOG
$RBII has a great strategy to combat the opiod epidemic in the Midwest. Big market. $RBII
Hemp and CBD derivatives have been used for generations in traditional societies for its healing properties. $RBII
Cannophen was originally developed in the quest for alternative effective treatments for opioid addiction. $RBII
There will be nothing else like the Sandusky treatment center in the entire RustBelt. $RBII
$RBII expecting some more big reveals here soon.
$PAOG won't stay unaware much longer. Cats out of the bag on this.
Once news come $PAOG It's only a matter of time before this undervalued Cannabis player takes off.
$PAOG super cheap and Severely undervalued.
$RBII 3 fold business model does a great job making the most of this opportunity.
I'm reading between the lines on that one: More NEWS Ahead. $RBII
Technically its $PAOG that holds the distribution rights and conducted the launch at the Cannabis Cup, but yes, its definitely good for $RBII
$PAOG Cannophen is a 1 to 1 full spectrum THC and CBD distillate.
Sitting very undervalued I'd say. $PAOG
$PAOG Cannophen all CBD variant should be here by Q3 or Q4 of this year. Fantastic.
$PAOG widespread distribution in Michigan coming up next quarter
$PAOG stil gaining critical awareness.
$PAOG great level for accumulation.
$RBII so many developments yet to be unveiled. Quite sure we get an update soon.
$PAOG is going to be the smash hit MJ play of the summer. Bit upside coming IMHO.
$PAOG sitting on a gold mine with Cannophen capsules.
$PAOG Cannophen is looking at a major distribution deal coming up for the region.
CBD only Cannophen opens alot of doors for $RBII
$RBII awareness coming to a tipping point.
After read recent PR i have feeling we have more news coming imo $RBII
A nice fat PR would really set this on its way. $PAOG